Number of Shares
10,498.00
Current Holdings Value*
$2.20 Mil
% of Portfolio
5.08%
Total Estimate Gain
$121,470.00
% of Total Estimate Gain
4.97%

AlphaCentric Life Sciences and Healthcare Fund's AbbVie Inc Holding Summary

As of 2025-03-31, AlphaCentric Life Sciences and Healthcare Fund held 10,498.00 shares of AbbVie Inc(ABBV), totaling $2.20 Mil. This investment constitutes 5.08% of their stock portfolio, and AlphaCentric Life Sciences and Healthcare Fund now holds 0% of the outstanding AbbVie Inc(ABBV) stock.

The initial trade took place in 2019Q4. And since then AlphaCentric Life Sciences and Healthcare Fund has made 2 purchases of ABBV, at an average price of $179.30, for a total of 13,618.00 shares. In addition, there have been 3 sales at an average price of $177.50 for 3,120.00 shares. Based on historical transaction data and ABBV's current price of $191.40, AlphaCentric Life Sciences and Healthcare Fund's estimated gain on his ABBV holdings is $121,470.00, reflecting a 4.97% gain to date.

AlphaCentric Life Sciences and Healthcare Fund ABBV ($191.40) Holding Chart

AlphaCentric Life Sciences and Healthcare Fund ABBV ($191.40) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1